LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Jay Gordon <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Fri, 4 May 2007 22:05:12 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (60 lines)
What a mess.

Bill, Bob, Martha  .  .  . any of you .  .  . can you fix this?

CORDARO NAMED INTERIM
IBLCE EXECUTIVE DIRECTOR

J. B. Cordaro has been named Interim IBLCE Executive Director until a new
Executive Director is selected.  He has over 40 years of experience in U.S.
and international food and nutrition programs. He has developed and managed
international food assistance projects, participated in and led the policy
deliberations of international organizations, and worked with business,
public and NGO/CSO representatives to build bridges of consensus for
programs and policies.

Mr. Cordaro graduated from Loyola University of the South with a B.S. in
government, economics, and philosophy; attended the Georgetown University
Graduate School of Foreign Service and received an advanced degree with an
emphasis on nutrition policy planning from Cornell University.

Mr. Cordaro will work two days a week at the IBLCE International Offices.

                   
Effective April 10, 2007.
http://www.crnusa.org/o3companies.html


HEINZ SUBSIDIARY SIGNS INFANT FORMULA LICENSE WITH MARTEK
May 1, 2002
>From a press release
COLUMBIA, Md.- Martek Biosciences Corporation (Nasdaq: MATK) today announced
that Heinz Wattie's Limited (A subsidiary of the H.J. Heinz Company) has
signed a non-exclusive license agreement for Martek's technology relating to
the use of long-chain polyunsaturated fatty acids in infant formula. The
agreement provides for initial cash payments and would give Martek an
ongoing royalty upon Heinz's introduction of products using Martek's
technology for docosahexaenoic acid ("DHA") and arachidonic acid ("ARA").
The license covers Australia, New Zealand, and certain Pacific Islands.
"Martek is pleased to have Heinz as a partner in supplying better nutrition
to infants," said Henry Linsert, Jr., Chairman and CEO of Martek Biosciences
Corporation.
Martek Biosciences Corporation develops, manufactures and sells products
from microalgae. The Company's products include: (1) specialty, nutritional
oils for infant formula; (2) nutritional supplements and food ingredients
that may play a beneficial role in promoting mental and cardiovascular
health, and in the development of the eyes and central nervous system in
newborns; and (3) new, powerful fluorescent markers for diagnostics, rapid
miniaturized screening, and gene and protein detection.

 

             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
Mail all commands to [log in to unmask]
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or [log in to unmask])
To unsubscribe: unsubscribe lactnet or ([log in to unmask])
To reach list owners: [log in to unmask]

ATOM RSS1 RSS2